http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101612139-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-303 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
filingDate | 2009-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101612139-B1 |
titleOfInvention | Liver cancer drug |
abstract | Novel pharmaceutical compositions and methods of treatment for treating or preventing hepatocellular carcinoma are provided. A pharmaceutical composition for the treatment and prevention of liver cancer is obtained by combining a chemotherapeutic agent and an anti-glypican 3 antibody. Also provided is a method for treating or preventing liver cancer comprising chemotherapeutic agents as an active ingredient for use in combination with an anti-glypican 3 or as an active ingredient for use in combination with a chemotherapeutic agent, or in combination with an anti- ≪ / RTI > are disclosed. The combined use of a chemotherapeutic agent and an anti - glypican 3 antibody shows a better therapeutic effect than when a chemotherapeutic agent is used alone, and reduces side effects caused by chemotherapeutic agent liver cancer treatment. |
priorityDate | 2008-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1071.